Solcoseryl

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Solcoseryl is a component of calf blood indicated to improve healing of the skin, mouth, or cornea.

Generic Name
Solcoseryl
DrugBank Accession Number
DB15794
Background

Not Available

Type
Biotech
Groups
Investigational
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Used in combination to treatCold soreCombination Product in combination with: Polidocanol (DB06811)•••••••••••••••••
Treatment ofCorneal inflammation•••••••••••••••
Treatment ofCorneal lesion•••••••••••••••
Treatment ofCorneal ulceration•••••••••••••••
Used in combination to treatGingivitisCombination Product in combination with: Polidocanol (DB06811)•••••••••••••••••
Associated Therapies
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Solcoseryl Eye GelGelOphthalmicA. MENARINI SINGAPORE PTE. LTD.2020-09-08Not applicableMalaysia flag
SOLCOSERYL EYE GEL 20%Gel20 %OphthalmicA. MENARINI SINGAPORE PTE. LTD.1990-05-21Not applicableSingapore flag
SOLCOSERYL JELLYJellyTopicalA. MENARINI SINGAPORE PTE. LTD.2020-09-08Not applicableMalaysia flag
SOLCOSERYL JELLY 2 g/20 gGel2 g/20gTopicalA. MENARINI SINGAPORE PTE. LTD.1990-02-22Not applicableSingapore flag
SOLCOSERYL OINTMENTOintmentTopicalA. MENARINI SINGAPORE PTE. LTD.2020-09-08Not applicableMalaysia flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
SOLCOSERYL ADHEZIV DIS PATI, 5 GSolcoseryl (2 mg) + Polidocanol (10 mf)PatchOralMEDA PHARMA İLAÇ SAN. VE TİC. LTD. ŞTİ.2013-10-03Not applicableTurkey flag
SOLCOSERYL DENTAL ADHESIVE PASTESolcoseryl (2.125 mg/g) + Polidocanol (10 mg/g)PasteDentalA. MENARINI SINGAPORE PTE. LTD.2020-09-082022-03-03Malaysia flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available

References

General References
  1. Malaysia NPRA: Solcoseryl eye gel [Link]
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3Not Yet RecruitingTreatmentOral Mucositis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
PatchOral
PasteDental
GelOphthalmic
GelOphthalmic20 %
JellyTopical
GelTopical2 g/20g
OintmentTopical
OintmentTopical1 g/20g
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at August 28, 2020 22:40 / Updated at May 14, 2021 01:08